Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444664 | PMC |
http://dx.doi.org/10.1164/rccm.201810-1949ED | DOI Listing |
Eur Respir Rev
July 2024
Department of Pulmonology, CK Birla Group of Hospitals, Kolkata, India
Recent bronchiectasis studies from large-scale multinational, multicentre registries have demonstrated that the characteristics of the disease vary according to geographic region. However, most perspectives on bronchiectasis are dominated by data from Western countries. This review intends to provide an Asian perspective on the disease, focusing on the established registries in India, Korea and China.
View Article and Find Full Text PDFEur Respir Rev
July 2024
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
Bronchiectasis is marked by bronchial dilatation, recurrent infections and significant morbidity, underpinned by a complex interplay between microbial dysbiosis and immune dysregulation. The identification of distinct endophenotypes have refined our understanding of its pathogenesis, including its heterogeneous disease mechanisms that influence treatment and prognosis responses. Next-generation sequencing (NGS) has revolutionised the way we view airway microbiology, allowing insights into the "unculturable".
View Article and Find Full Text PDFSemin Respir Crit Care Med
August 2021
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Bronchiectasis is a chronic condition of global relevance resulting in permanent and irreversible structural airway damage. Bacterial infection in bronchiectasis is well studied; however, recent molecular studies identify fungi as important pathogens, either independently or in association with bacteria. species are established fungal pathogens in cystic fibrosis and their role is now increasingly being recognized in noncystic fibrosis bronchiectasis.
View Article and Find Full Text PDFBreathe (Sheff)
December 2019
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Unlabelled: Non-cystic fibrosis bronchiectasis (NCFB) is a neglected and orphan disease with poor advances through the 20th century. However, its prevalence is rising and with this come new challenges for physicians. Few guidelines are available to guide clinicians on how to diagnose and manage patients with NCFB.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!